OneVentures preps new healthcare fund but faces losses on its $170m Fund III from 2016


OneVentures plans a new healthcare fund despite losses in its previous fund, raising questions about its biggest investments.
AI Summary available — skim the key points instantly. Show AI Generated Summary
Show AI Generated Summary

Michelle Deaker’s OneVentures, widely regarded as one of Australia’s shrewdest venture capital investors, is gearing up to raise a new healthcare-focused fund later this year. However, the effort won’t be without prospective investors questioning the exit status at its biggest moneymakers, including the $1.3 billion vaccine patch start-up Vaxxas and the $450 million analytics software player Phocas.

The venture capital investor has told its backers it expects to launch a dedicated healthcare fund in the December quarter, once it has wrapped up the $250 million raising it kicked off for its Growth Fund VII in August.

Loading...

Was this article displayed correctly? Not happy with what you see?

We located an Open Access version of this article, legally shared by the author or publisher. Open It
Tabs Reminder: Tabs piling up in your browser? Set a reminder for them, close them and get notified at the right time.

Try our Chrome extension today!


Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more

Facebook

Save articles to reading lists
and access them on any device


Share this article with your
friends and colleagues.
Earn points from views and
referrals who sign up.
Learn more

Facebook

Save articles to reading lists
and access them on any device